Dr. Falk Pharma announces positive results from its pivotal phase 3 trial on norucholic acid in primary sclerosing cholangitis
Freiburg, May 7th, 2025 Study results demonstrate superiority of norucholic acid (NCA) over placebo in the combined primary endpoint. There is currently no approved medicine
Antalpha Announces Launch of Initial Public Offering
SINGAPORE, May 06, 2025 (GLOBE NEWSWIRE) — Antalpha Platform Holding Company (“Antalpha” or the “Company”) today announced that it has launched the roadshow for its
Antalpha Announces Launch of Initial Public Offering
SINGAPORE, May 06, 2025 (GLOBE NEWSWIRE) — Antalpha Platform Holding Company (“Antalpha” or the “Company”) today announced that it has launched the roadshow for its
Meltwater unveils Mira, latest AI innovations in 2025 Mid-Year Product Release
SAN FRANCISCO, May 06, 2025 (GLOBE NEWSWIRE) — Meltwater, a global leader in media, social and consumer intelligence, today unveiled its latest innovations, led by
Bitget Amplifies Global Leadership and Community Impact with Strong Presence at TOKEN2049 Dubai
DUBAI, United Arab Emirates, May 05, 2025 (GLOBE NEWSWIRE) — Bitget, the leading cryptocurrency exchange and Web3 company, has wrapped up an impactful and illuminating
Felix Bravo Named Managing Director, International at eXp Realty
Felix Bravo Named Managing Director, International at eXp Realty Driving the Next Chapter of Global Agent-Centric Growth BELLINGHAM, Wash., May 02, 2025 (GLOBE NEWSWIRE) —